inSili.com offers an elite source of intellectual property and unique expertise for innovative pharmaceutical and biotechnological research and development. We provide know-how, coaching and consulting, and world-leading technology services for artificial intelligence in drug design. Our clients are among the world's top pharmaceutical, chemical, biotechnology and cosmeceutical enterprises. Founded in 2013 as an ETH spin-off company, inSili.com's exclusive technology platform, stellar track record and solid partnerships enable a rennaissance of small-molecule drug discovery and provide the foundation for custom-tailored medicines of the future.